F2 and antiphospholipid syndrome: The most commonly reported was homocystinaemia (12%), followed by anti-phospholipid syndrome (4%), mutations in Factor V Leiden (3%) and prothrombin (3%) genes, JAK2V617F mutation (1%), and antithrombin III (1%) and protein S (1%) deficiencies.